acquired
Stage
About
AbFero Pharmaceuticals Inc. is a clinical stage pharmaceutical company focusing on developing oral iron chelators to treat diseases caused by iron overload, such as transfusional iron overload and age-related macular degeneration.
Explore AbFero Pharmaceuticals Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.